The Pharmaceutical Care Management Association—a trade lobby representing pharmacy benefit managers—argues a state law that would force companies to divest from drugstores could leave patients without access to critical medications.

A bad outcome for Johnson & Johnson MedTech just got worse. A jury previously ordered the company to pay $147M, but the new total is $442M.

Lauren Moody and her attorneys believe the damages against Oscar Health could climb to $30M when factoring in interest, attorney fees and fines. 

Staff purged from the Department of Health and Human Services by Elon Musk's Department of Government Efficiency claim their termination notices contained bogus information and other inaccuracies that were cited as justifications for performance-based firings. The plaintiffs are seeking unspecified damages.

The family of Grace Schara claims Ascension Health’s St. Elizabeth Hospital gave their unvaccinated daughter a cocktail of drugs that ultimately caused her death. The case has earned the attention of Children’s Health Defense, a controversial nonprofit formed by HHS Secretary Robery F. Kennedy Jr. 

Returning CEO Stephen Hemsley will receive a base salary of $1 million per year, alongside a one-time bonus package in stocks worth $60 million. He is not eligible to receive future bonuses until 2028, the company confirmed in a SEC filing. 

A series of lawsuits has been filed against Plenary Health Care Partnerships, the consortium hired by the Ontario government to build Humber River Health’s new Toronto hospital, alleging floors are deteriorating and the water system was faulty.

The newly signed law, known as Act 264, bans pharmacy benefit managers from owning pharmacies in the state. It's scheduled to go into effect beginning in 2026.